DocGo Inc.: insider trades · United States · SEC (Form 4)

About DocGo Inc.

DocGo Inc. (NASDAQ: DCGO) is a U.S.-based healthcare services company headquartered in New York, United States. Founded in 2015 under the name Ambulnz, the company was built around the idea that a meaningful share of care can be delivered outside the hospital setting through mobile clinical teams, ambulances, home-based services, and digital coordination tools. Over time, DocGo has evolved from a transportation-focused operator into a broader technology-enabled care delivery platform. Today, the business is centered on two main operating pillars: mobile health services and medical transportation services. Mobile health includes in-home care, testing and vaccination programs, mobile phlebotomy, remote patient monitoring, and other decentralized care delivery workflows. Medical transportation covers scheduled ambulance services, interfacility transfers, and dedicated transport solutions. The company’s proprietary platform is intended to help manage dispatch, scheduling, patient routing, and logistics, giving it a more integrated offering than a pure ambulance provider. From a market-positioning perspective, DocGo sits in an attractive but competitive niche. Its value proposition is built on combining field execution, clinical staffing, and software-enabled coordination in one platform. That matters in the U.S. healthcare system, where hospitals, health systems, insurers, and public agencies face constant pressure to lower costs, reduce congestion, improve patient access, and extend care into the community. DocGo’s model is therefore aligned with several durable healthcare trends, including care decentralization, home-based services, and operational outsourcing. The company’s competitive advantages are partly operational and partly technological. Its ability to deploy certified healthcare professionals at scale, together with transportation assets and digital workflow tools, can create efficiency for customers that need both clinical capability and logistics support. At the same time, DocGo remains exposed to contract timing, customer concentration, and public-sector budget cycles, which can introduce revenue volatility when large programs wind down or rebid. Geographically, DocGo is primarily a U.S. business, with operations across the country and a presence in the United Kingdom. Recent disclosures and press releases indicate continued expansion of its service footprint, including new medical transportation agreements, mobile vaccination programs, and broader telehealth capabilities. A notable development in 2025 was the acquisition of SteadyMD, which expanded DocGo’s telehealth and virtual care capabilities across all 50 states. The company also reported new health-system contracts in the New York metro area and continued growth in mobile health use cases. For investors, DocGo is best understood as a hybrid healthcare services platform listed on the NASDAQ in the United States: part ambulance and transport operator, part mobile care provider, and increasingly part digital healthcare enabler. Its long-term opportunity depends on execution, contract wins, and the company’s ability to convert a fragmented care-delivery landscape into a scalable, technology-supported operating model.